Your session is about to expire
← Back to Search
Stereotactic Radiosurgery for Meningioma
Study Summary
This trial is testing nivolumab with or without ipilimumab as a treatment for recurrent meningioma. Nivolumab is an immunotherapy drug that may help the body's immune system attack the cancer. Ipilimumab is also an immunotherapy drug. Stereotactic radiosurgery is a type of radiation therapy.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 2 trial • 32 Patients • NCT01573702Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To what extent has Stereotactic Radiosurgery been explored in other research studies?
"At the present moment, 765 clinical trials for Stereotactic Radiosurgery are underway. Of those active studies, 86 have reached Phase 3 of clinical research. Despite Pittsburgh being a primary hub for this study, 42755 sites across the globe are offering access to these treatments."
To what extent has this research been implemented within U.S. medical practices?
"This trial is currently recruiting from 14 sites scattered throughout United States, including Miami, Los Angeles and Westwood. To reduce strain on the patient's time and budget, we encourage enrollees to choose a location close by their residence."
To what maladies has Stereotactic Radiosurgery proven most efficacious?
"Stereotactic Radiosurgery is traditionally used for the treatment of anti-angiogenic therapy, but can also be beneficial for patients with malignant neoplasms, unresectable melanoma and squamous cell carcinoma."
How many participants are involved in this research endeavor?
"For this medical study, 15 participants who meet the conditions of eligibility can take part. Those interested in enrolling have two options: The University of Miami Miller School of Medicine-Sylvester Cancer Center situated in Florida and USC / Norris Comprehensive Cancer Centre positioned in California."
Are there any openings for participants in this clinical investigation?
"According to the clinicaltrials.gov website, this research trial is actively recruiting patients. The initial posting was done on November 21st 2018 and has been recently updated as of November 15th 2022."
Share this study with friends
Copy Link
Messenger